120 related articles for article (PubMed ID: 3412036)
1. Adriamycin, vincristine and mitomycin C as first and second line therapy for advanced breast carcinoma.
Harding M; Sangster G; Milsted RA; Kaye SB; Calman KC
Med Oncol Tumor Pharmacother; 1988; 5(2):125-8. PubMed ID: 3412036
[TBL] [Abstract][Full Text] [Related]
2. Vincristine, adriamycin, and mitomycin (VAM) therapy for previously treated breast cancer. A preliminary report.
Oster MW; Park Y
Cancer; 1983 Jan; 51(2):203-5. PubMed ID: 6821812
[TBL] [Abstract][Full Text] [Related]
3. Adriamycin (doxorubicin), vinblastine, and mitomycin C combination chemotherapy in refractory breast carcinoma.
Luikart SD; Witman GB; Portlock CS
Cancer; 1984 Oct; 54(7):1252-5. PubMed ID: 6467151
[TBL] [Abstract][Full Text] [Related]
4. Adriamycin, vinblastine and mitomycin C as second-line chemotherapy in advanced breast cancer.
Sulkes A; Gez E; Pfeffer MR; Catane R; Isacson R; Biran S
Cancer Chemother Pharmacol; 1986; 18(2):162-7. PubMed ID: 3791561
[TBL] [Abstract][Full Text] [Related]
5. Adriamycin, dibromodulcitol, and mitomycin combination chemotherapy for patients with metastatic breast carcinoma previously treated with cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prednisone.
Pinnamaneni K; Yap HY; Buzdar AU; Distefano A; Blumenschein GR
Cancer; 1984 May; 53(9):1841-4. PubMed ID: 6546706
[TBL] [Abstract][Full Text] [Related]
6. Treatment of advanced breast cancer with two doxorubicin-containing regimens.
Harris MA; Byrne PJ; Smith FP; Ueno W; Schlesinger C; Oishi S; Schein PS
Am J Clin Oncol; 1984 Feb; 7(1):51-8. PubMed ID: 6421145
[TBL] [Abstract][Full Text] [Related]
7. Adriamycin alone or combined with vincristine in the treatment of advanced breast cancer.
Steiner R; Stewart JF; Cantwell BM; Minton MJ; Knight RK; Rubens RD
Eur J Cancer Clin Oncol; 1983 Nov; 19(11):1553-7. PubMed ID: 6357805
[TBL] [Abstract][Full Text] [Related]
8. Adriamycin and mitomycin C as initial chemotherapy for advanced breast cancer.
Amiel SA; Stewart JF; Earl HM; Knight RK; Rubens RD
Eur J Cancer Clin Oncol; 1984 May; 20(5):631-4. PubMed ID: 6428893
[TBL] [Abstract][Full Text] [Related]
9. [A randomized trial comparing ACF (adriamycin, cyclophosphamide, ftorafur) and ACF/MVMF (mitomycin C, vincristine, methotrexate, ftorafur)--a non-cross-resistant alternating chemotherapy of recurrent and advanced breast cancer].
Mukaiyama T; Ogawa M; Horikoshi N; Inoue K; Tada A; Ueno K; Yamazaki H; Nakamura T; Ito Y; Inagaki J
Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 1):327-32. PubMed ID: 2494947
[TBL] [Abstract][Full Text] [Related]
10. Vincristine, doxorubicin and mitomycin (VAM) in patients with advanced breast cancer previously treated with cyclophosphamide, methotrexate and fluorouracil (CMF). A clinical trial of the Piedmont Oncology Association (POA).
Shipp SK; Muss HB; Westrick MA; Cooper MR; Jackson DV; Richards FC; White DR; Stuart JJ; Christian RM; Ramseur W
Cancer Chemother Pharmacol; 1983; 11(2):130-3. PubMed ID: 6354509
[TBL] [Abstract][Full Text] [Related]
11. [Vincristine, adriamycin, mitomycin-C and UFT (VAM-UFT) therapy in progressive or recurrent breast cancer].
Yasutake K; Imamura Y; Yoshimura Y; Oya M; Matsushita K; Hozumi T; Katou J; Okutani T; Irie K
Gan To Kagaku Ryoho; 1989 Jul; 16(7):2373-9. PubMed ID: 2502072
[TBL] [Abstract][Full Text] [Related]
12. Randomized trial of doxorubicin alone or combined with vincristine and mitomycin C in women with metastatic breast cancer.
Ingle JN; Mailliard JA; Schaid DJ; Krook JE; Gerstner JB; Pfeifle DM; Marschke RF; Long HJ; McCormack GW; Foley JF
Am J Clin Oncol; 1989 Dec; 12(6):474-80. PubMed ID: 2686393
[TBL] [Abstract][Full Text] [Related]
13. Doxorubicin versus mitomycin versus doxorubicin plus mitomycin in advanced breast cancer: a randomized study.
Andersson M; Daugaard S; von der Maase H; Mouridsen HT
Cancer Treat Rep; 1986 Oct; 70(10):1181-6. PubMed ID: 3530444
[TBL] [Abstract][Full Text] [Related]
14. 5-Fluorouracil + Oncovin + Adriamycin + mitomycin C (FOAM): an effective program for breast cancer, even for disease refractory to previous chemotherapy. A Northern California Oncology Group (NCOG) Study.
Friedman MA; Marcus FS; Cassidy MJ; Resser KJ; Kohler M; Hendrickson CG; Reynolds R; Johnson D; Kilbridge T; Yu K; Cruicitt M
Cancer; 1983 Jul; 52(2):193-7. PubMed ID: 6344976
[TBL] [Abstract][Full Text] [Related]
15. [Combination chemotherapy with mitomycin C, methotrexate, and vincristine (MMV) for metastatic breast cancer refractory to adriamycin].
Nomura Y; Kanda K; Tashiro H; Hamada Y; Saeki K
Gan To Kagaku Ryoho; 1983 Mar; 10(3):824-8. PubMed ID: 6411002
[TBL] [Abstract][Full Text] [Related]
16. [Alternating combination chemotherapy (VIP-DMF) in patients with advanced adenocarcinoma of the prostate].
Yoshimoto J; Ochi J; Tanahashi T; Nanba K; Saegusa M; Hara M; Akagi T; Obama T; Tsushima T; Ozaki Y
Gan To Kagaku Ryoho; 1987 Feb; 14(2):434-9. PubMed ID: 2434029
[TBL] [Abstract][Full Text] [Related]
17. A randomised trial comparing combination chemotherapy using mitomycin C, mitozantrone and methotrexate (3M) with vincristine, anthracycline and cyclophosphamide (VAC) in advanced breast cancer.
Powles TJ; Jones AL; Judson IR; Hardy JR; Ashley SE
Br J Cancer; 1991 Aug; 64(2):406-10. PubMed ID: 1892775
[TBL] [Abstract][Full Text] [Related]
18. Fixed dose short course mitomycin C with vincristine in advanced pre-treated breast cancer.
Millward MJ; Hendrick A; Cantwell BM
Ann Oncol; 1990 Sep; 1(5):373-4. PubMed ID: 2124501
[No Abstract] [Full Text] [Related]
19. Weekly adriamycin versus VAC in advanced breast cancer. A randomized trial.
Gundersen S; Kvinnsland S; Klepp O; Kvaløy S; Lund E; Høst H
Eur J Cancer Clin Oncol; 1986 Dec; 22(12):1431-4. PubMed ID: 3595668
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy induces regression of brain metastases in breast carcinoma.
Rosner D; Nemoto T; Lane WW
Cancer; 1986 Aug; 58(4):832-9. PubMed ID: 3755076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
